Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01822821 · ClinicalTrials.gov registry record · NA

Pain Control After Cardiac Surgery Using Intravenous Acetaminophen

A NA study, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
150
Enrollment target

NCT01822821: Completed NA study, sponsored by The Cleveland Clinic.

NCT01822821 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01822821, a NA study, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target

Study Summary

Evaluate the efficacy of IV acetaminophen; compared to a placebo, in reducing opioid consumption and/or pain intensity scores after cardiac surgery.

Primary Outcome

Evaluate the noninferiority and efficacy of IV acetaminophen; compared to a placebo, in reducing opioid consumption a after cardiac surgery. Total opioid consumption is defined as the total amount amount of opioids administered to patients converted to mg morphine equivalents.

Interventions

  • DRUG Placebo
  • DRUG IV Acetaminophen

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2013-03
Est. Completion 2015-03
Phase NA
The Cleveland Clinic

688 total trials

What the finished NCT01822821 record still lists

NCT01822821 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT01822821 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01822821 about?

NCT01822821 is a clinical study titled "Pain Control After Cardiac Surgery Using Intravenous Acetaminophen". Evaluate the efficacy of IV acetaminophen; compared to a placebo, in reducing opioid consumption and/or pain intensity scores after cardiac surgery.

What is the current status of trial NCT01822821?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2013-03. Estimated completion is 2015-03.

What interventions are being tested in trial NCT01822821?

The interventions under investigation include: Placebo (DRUG), IV Acetaminophen (DRUG).

Who is sponsoring clinical trial NCT01822821?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01822821's enrollment target sits among peer trials

150 661st of 2000 higher than 1,299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01822821, the US trial registry maintained by the National Library of Medicine. NCT01822821 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.